Cas:22348-64-7 (22S)-22-hydroxycholesterol manufacturer & supplier

We serve Chemical Name:(22S)-22-hydroxycholesterol CAS:22348-64-7 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

(22S)-22-hydroxycholesterol

Chemical Name:(22S)-22-hydroxycholesterol
CAS.NO:22348-64-7
Synonyms:22S-hydroxycholesterol;22(R)-HYDROXYCHOLESTEROL;beta2-Solamargine;22(S)-Hydroxycholesterol
Molecular Formula:C27H46O2
Molecular Weight:402.65300
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:40.46000
Exact Mass:402.35000
LogP:6.35950

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:NONH for all modes of transpor
Packing Group:


Contact us for information like 22S-hydroxycholesterol chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,22(S)-Hydroxycholesterol physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,22S-hydroxycholesterol Use and application,22(R)-HYDROXYCHOLESTEROL technical grade,usp/ep/jp grade.


Related News: Catalent, a global leader in clinical supply services, recently announced the launch of its new CTSuccessTM clinical trial planning service, designed to support trial sponsors with earlier, more proactive and robust clinical supply chain planning, and reduce the risk of delays and budget overspend common to clinical trials as they progress. (22S)-22-hydroxycholesterol manufacturer Due to the cyclic nature of the upstream chemical products of the API, it is expected that the impact of price fluctuations of raw materials on the performance of API companies is unavoidable, but companies with thick product lines and the ability to produce intermediates are expected to minimize the upstream price impact. (22S)-22-hydroxycholesterol supplier Cases recorded in Thailand, Taiwan, Germany, Vietnam, Japan, France and the United States involved patients who had not been to China. (22S)-22-hydroxycholesterol vendor China will use its national drug bulk-buy scheme to lower the price of drugs currently sold at higher prices compared with other markets, it said in an official statement. (22S)-22-hydroxycholesterol factory Cases recorded in Thailand, Taiwan, Germany, Vietnam, Japan, France and the United States involved patients who had not been to China.